Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Announces Advances in Identifying and Preventing siRNA-Mediated Immune Stimulation Mar 23, 2010 Tekmira Announces Advances in Identifying and Preventing siRNA-Mediated Immune Stimulation 18 KB ... Read more Summary ToggleTekmira Pharmaceuticals Provides Corporate Update and Reports 2009 Audited Results Mar 17, 2010 Tekmira Pharmaceuticals Provides Corporate Update and Reports 2009 Audited Results 28.5 KB ... Read more Summary ToggleTekmira and Pfizer Initiate New Research Collaboration Mar 16, 2010 Tekmira and Pfizer Initiate New Research Collaboration 17.3 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory 2009 Audited Results and Corporate Update Mar 15, 2010 Tekmira Pharmaceuticals Conference Call Advisory 2009 Audited Results and Corporate Update 12.8 KB ... Read more Summary ToggleTekmira Presents ApoB SNALP Data at AsiaTIDES RNAi Scientific Conference Feb 23, 2010 Tekmira Presents ApoB SNALP Data at AsiaTIDES RNAi Scientific Conference 18.1 KB -Second Generation ApoB SNALP to Enter Phase 1/2 Clinical Trial in Second Half of 2010- ... Read more Summary ToggleTekmira Pharmaceuticals Announces 2010 Milestones Feb 09, 2010 -Five SNALP Based RNAi Products Anticipated to be in Clinical Development in 2010- ... Read more Summary ToggleTekmira Pharmaceuticals to Present at 12th Annual BIO CEO & Investor Conference Feb 04, 2010 Tekmira Pharmaceuticals to Present at 12th Annual BIO CEO & Investor Conference 14.2 KB ... Read more Summary ToggleTekmira Pharmaceuticals Appoints New Chairman and Two New Independent Directors Jan 28, 2010 Tekmira Pharmaceuticals Appoints New Chairman and Two New Independent Directors 17.5 KB -New Directors Add to Tekmira’s Drug Development and Capital Markets Capabilities - ... Read more Summary ToggleTekmira Makes Significant Improvements in the Potency of its Leading RNAi Delivery Platform Jan 19, 2010 Tekmira Makes Significant Improvements in the Potency of its Leading RNAi Delivery Platform 20.1 KB -New research published in Nature Biotechnology confirms 10-fold improvements in SNALP potency- ... Read more Summary ToggleTekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial Jan 07, 2010 Tekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial 21.1 KB ... Read more Pagination First page First Previous page Previous … Page 46 Current page 47 Page 48 Page 49 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Announces Advances in Identifying and Preventing siRNA-Mediated Immune Stimulation Mar 23, 2010 Tekmira Announces Advances in Identifying and Preventing siRNA-Mediated Immune Stimulation 18 KB ... Read more Summary ToggleTekmira Pharmaceuticals Provides Corporate Update and Reports 2009 Audited Results Mar 17, 2010 Tekmira Pharmaceuticals Provides Corporate Update and Reports 2009 Audited Results 28.5 KB ... Read more Summary ToggleTekmira and Pfizer Initiate New Research Collaboration Mar 16, 2010 Tekmira and Pfizer Initiate New Research Collaboration 17.3 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory 2009 Audited Results and Corporate Update Mar 15, 2010 Tekmira Pharmaceuticals Conference Call Advisory 2009 Audited Results and Corporate Update 12.8 KB ... Read more Summary ToggleTekmira Presents ApoB SNALP Data at AsiaTIDES RNAi Scientific Conference Feb 23, 2010 Tekmira Presents ApoB SNALP Data at AsiaTIDES RNAi Scientific Conference 18.1 KB -Second Generation ApoB SNALP to Enter Phase 1/2 Clinical Trial in Second Half of 2010- ... Read more Summary ToggleTekmira Pharmaceuticals Announces 2010 Milestones Feb 09, 2010 -Five SNALP Based RNAi Products Anticipated to be in Clinical Development in 2010- ... Read more Summary ToggleTekmira Pharmaceuticals to Present at 12th Annual BIO CEO & Investor Conference Feb 04, 2010 Tekmira Pharmaceuticals to Present at 12th Annual BIO CEO & Investor Conference 14.2 KB ... Read more Summary ToggleTekmira Pharmaceuticals Appoints New Chairman and Two New Independent Directors Jan 28, 2010 Tekmira Pharmaceuticals Appoints New Chairman and Two New Independent Directors 17.5 KB -New Directors Add to Tekmira’s Drug Development and Capital Markets Capabilities - ... Read more Summary ToggleTekmira Makes Significant Improvements in the Potency of its Leading RNAi Delivery Platform Jan 19, 2010 Tekmira Makes Significant Improvements in the Potency of its Leading RNAi Delivery Platform 20.1 KB -New research published in Nature Biotechnology confirms 10-fold improvements in SNALP potency- ... Read more Summary ToggleTekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial Jan 07, 2010 Tekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial 21.1 KB ... Read more Pagination First page First Previous page Previous … Page 46 Current page 47 Page 48 Page 49 … Next page Next Last page Last
